Cargando...
NYSE: V
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueIngresos Totales | $40.0B+11.3% | $35.9B+10.0% | $32.7B+11.4% | $29.3B+21.6% | $24.1B+10.3% | $21.8B-4.9% | $23.0B+11.5% | $20.6B+12.3% | $18.4B+21.7% | $15.1B |
| Cost of RevenueCosto de Ventas | — | — | — | — | — | — | — | — | — | — |
| Gross ProfitUtilidad Bruta | — | — | — | — | — | — | — | — | — | — |
| Research & DevelopmentInvestigación y Desarrollo | — | — | — | — | — | — | — | — | — | — |
| Selling, General & AdministrativeGastos Generales y Adm. | $1.9B+20.5% | $1.6B+20.2% | $1.3B+11.4% | $1.2B+21.2% | $985.0M-10.1% | $1.1B-8.4% | $1.2B+4.5% | $1.1B+8.0% | $1.1B+33.2% | $796.0M |
| Total Operating ExpensesGastos Operativos Totales | $16.0B+29.8% | $12.3B+5.8% | $11.7B+11.0% | $10.5B+26.5% | $8.3B+6.9% | $7.8B-2.6% | $8.0B+4.2% | $7.7B+23.2% | $6.2B-13.7% | $7.2B |
| Operating IncomeUtilidad Operativa | $24.0B+1.7% | $23.6B+12.4% | $21.0B+11.6% | $18.8B+19.0% | $15.8B+12.2% | $14.1B-6.1% | $15.0B+15.8% | $13.0B+6.7% | $12.1B+54.1% | $7.9B |
| Other Income/(Expense), NetOtros Ingresos/(Gastos), Neto | $789.0M-18.0% | $962.0M+41.3% | $681.0M+200.6% | -$677.0M-187.7% | $772.0M+249.6% | -$516.0M+3.2% | -$533.0M+12.9% | -$612.0M-8.7% | -$563.0M-201.3% | $556.0M |
| Pretax IncomeUtilidad Antes de Impuestos | $24.2B+1.2% | $23.9B+13.7% | $21.0B+16.0% | $18.1B+12.9% | $16.1B+16.5% | $13.8B-7.4% | $14.9B+16.2% | $12.8B+9.5% | $11.7B+46.0% | $8.0B |
| Tax ProvisionImpuestos | $4.1B-0.9% | $4.2B+10.9% | $3.8B+18.4% | $3.2B-15.3% | $3.8B+28.3% | $2.9B+4.3% | $2.8B+11.9% | $2.5B-49.8% | $5.0B+147.2% | $2.0B |
| Net IncomeUtilidad Neta | $20.1B+1.6% | $19.7B+14.3% | $17.3B+15.5% | $15.0B+21.5% | $12.3B+13.3% | $10.9B-10.0% | $12.1B+17.3% | $10.3B+53.8% | $6.7B+11.8% | $6.0B |
| EBITDA | $25.2B+2.4% | $24.6B+12.2% | $21.9B+11.5% | $19.7B+18.5% | $16.6B+11.9% | $14.8B-5.2% | $15.7B+15.4% | $13.6B+6.8% | $12.7B+51.5% | $8.4B |
| Basic EPSUPA Básica | — | — | — | — | — | — | — | — | — | — |
| Diluted EPSUPA Diluida | — | — | — | — | — | — | — | — | — | — |